Eagle Pharmaceuticals Inc (EGRX) — Financial Flexibility Index
Eagle Pharmaceuticals Inc (EGRX) has a Financial Flexibility Index of 0.00x as of June 2023. Free cash flow of $-120.00K (operating CF $-126.00K minus capex $6.00K) represents 0% of total liabilities ($152.78 Million). Also explore net asset momentum of Eagle Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Eagle Pharmaceuticals Inc Financial Flexibility Index (2012–2022)
Historical Financial Flexibility Index trend for Eagle Pharmaceuticals Inc across 11 annual periods. Check asset allocation strategy of Eagle Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Eagle Pharmaceuticals Inc (2012–2022)
Year-by-year free cash flow to debt coverage for Eagle Pharmaceuticals Inc. For the full company profile including market capitalisation, see EGRX company net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2022 | 0.18x | $30.98 Million | $30.80 Million | $172.60 Million | ▼ -51.4% |
| 2021 | 0.37x | $28.54 Million | $28.22 Million | $77.28 Million | ▼ -50.6% |
| 2020 | 0.75x | $50.24 Million | $49.50 Million | $67.18 Million | ▼ -0.7% |
| 2019 | 0.75x | $56.76 Million | $55.99 Million | $75.38 Million | ▲ +11.6% |
| 2018 | 0.67x | $52.52 Million | $52.38 Million | $77.84 Million | ▼ -4.3% |
| 2017 | 0.71x | $64.11 Million | $58.92 Million | $90.92 Million | ▼ -40.5% |
| 2016 | 1.19x | $73.90 Million | $53.21 Million | $62.34 Million | ▲ +618.2% |
| 2015 | -0.23x | $-7.84 Million | $-9.72 Million | $34.26 Million | ▲ +66.3% |
| 2014 | -0.68x | $-13.80 Million | $-13.84 Million | $20.32 Million | ▼ -86.7% |
| 2013 | -0.36x | $-5.84 Million | $-5.88 Million | $16.05 Million | ▲ +49.5% |
| 2012 | -0.72x | $-15.52 Million | $-15.55 Million | $21.54 Million | — |